ERNA vs. MLSS
ERNA (Eterna Therapeutics Inc) and MLSS (Milestone Scientific Inc.) are both stocks. Both are in the Healthcare sector — ERNA in Biotechnology, MLSS in Medical Instruments & Supplies. Over the past 10 years, ERNA returned -62.07%/yr vs -18.21%/yr for MLSS. At a 0.06 correlation, their price movements are largely independent.
Performance
ERNA vs. MLSS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ERNA achieves a -79.80% return, which is significantly lower than MLSS's 39.89% return. Over the past 10 years, ERNA has underperformed MLSS with an annualized return of -62.07%, while MLSS has yielded a comparatively higher -18.21% annualized return.
ERNA
- 1D
- 2.19%
- 1M
- -7.55%
- 6M
- -81.50%
- YTD
- -79.80%
- 1Y
- -87.57%
- 3Y*
- -81.25%
- 5Y*
- -85.57%
- 10Y*
- -62.07%
MLSS
- 1D
- 7.58%
- 1M
- 9.11%
- 6M
- 29.94%
- YTD
- 39.89%
- 1Y
- -42.69%
- 3Y*
- -29.50%
- 5Y*
- -28.33%
- 10Y*
- -18.21%
ERNA vs. MLSS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ERNA Eterna Therapeutics Inc | -79.80% | -72.79% | -83.62% | -44.25% | -96.14% | -6.92% | 1.82% | 12.82% | -53.68% | -50.47% |
MLSS Milestone Scientific Inc. | 39.89% | -71.56% | 39.15% | 43.73% | -76.70% | -2.83% | 52.52% | 319.18% | -71.92% | -15.64% |
Correlation
The correlation between ERNA and MLSS is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Nov 3, 1995 | 0.06 |
The correlation between ERNA and MLSS shifts across timeframes, from 0.06 (all time) to 0.17 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ERNA:
$1.90M
MLSS:
$33.78M
ERNA:
-$23.80
MLSS:
-$0.08
ERNA:
$0.00
MLSS:
$8.93M
ERNA:
-$69.00K
MLSS:
$6.40M
ERNA:
-$11.25M
MLSS:
-$6.49M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ERNA vs. MLSS — Risk / Return Rank
ERNA
MLSS
ERNA vs. MLSS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eterna Therapeutics Inc (ERNA) and Milestone Scientific Inc. (MLSS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ERNA | MLSS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.09 | ||
| Sortino ratioReturn per unit of downside risk | -0.81 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 0.96 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | -0.94 | -0.68 | -0.26 |
| Martin ratioReturn relative to average drawdown | -1.38 | -0.96 | -0.42 |
Loading charts...
Drawdowns
ERNA vs. MLSS - Drawdown Comparison
The maximum ERNA drawdown since its inception was -100.00%, roughly equal to the maximum MLSS drawdown of -99.77%. Use the drawdown chart below to compare losses from any high point for ERNA and MLSS.
Loading charts...
Drawdown Indicators
| ERNA | MLSS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -99.77% | -0.23% |
Max Drawdown (1Y)Largest decline over 1 year | -93.32% | -63.03% | -30.29% |
Max Drawdown (3Y)Largest decline over 3 years | -99.67% | -81.47% | -18.20% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -90.91% | -9.09% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -94.72% | -5.28% |
Current DrawdownCurrent decline from peak | -100.00% | -99.55% | -0.45% |
Average DrawdownAverage peak-to-trough decline | -86.18% | -91.21% | +5.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 63.64% | 45.28% | +18.36% |
Volatility
ERNA vs. MLSS - Volatility Comparison
Eterna Therapeutics Inc (ERNA) and Milestone Scientific Inc. (MLSS) have volatilities of 26.61% and 25.47%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ERNA | MLSS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.61% | 25.47% | +1.14% |
Volatility (6M)Calculated over the trailing 6-month period | 130.04% | 61.75% | +68.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 151.77% | 88.32% | +63.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 114.08% | 84.94% | +29.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 149.04% | 87.52% | +61.52% |
Dividends
ERNA vs. MLSS - Dividend Comparison
Neither ERNA nor MLSS has paid dividends to shareholders.
Financials
ERNA vs. MLSS - Financials Comparison
This section allows you to compare key financial metrics between Eterna Therapeutics Inc and Milestone Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ERNA and MLSS have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ERNA has higher volatility (26.61%) compared to MLSS (25.47%). In terms of maximum drawdown, ERNA dropped -100.00% vs MLSS's -99.77%.
MLSS currently has the higher Sharpe Ratio (-0.49 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ERNA and MLSS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer